Dexcom (NASDAQ:DXCM) Combines Strong Growth With a Bullish Technical Setup
DexCom (DXCM) Stock May Trade At A 37% Discount On Cash Flow
DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued?
DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates
Is Wall Street Bullish or Bearish on DexCom Stock?
Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago
DexCom (NASDAQ:DXCM) Stands Out as an Affordable Growth Stock
Argus Research Maintains Buy on DexCom, Raises Price Target to $96
DexCom (DXCM) Q2 2026 Earnings Call Transcript
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $90
DexCom (DXCM) Recently Broke Out Above the 20-Day Moving Average
DexCom, Inc. (DXCM) Hit a 52 Week High, Can the Run Continue?
DexCom: Still A Cautious Buy Following Earnings
DexCom (DXCM) Stock Sees Fair Value Lift After Analyst Target Increases
Why DexCom (DXCM) Is Up 16.6% After Raising 2026 Outlook And Expanding Type 2 Access
DXCM Q2 Deep Dive: Expanded Access and Product Updates Drive Growth
Citigroup Maintains Buy on DexCom, Raises Price Target to $88
Dexcom tweaks full-year outlook after reporting 13% growth in Q2
Why Is DexCom (DXCM) Stock Rocketing Higher Today
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $90
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.